Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Other Non-Current Assets (2016 - 2020)

Monopar Therapeutics (MNPR) has disclosed Other Non-Current Assets for 5 consecutive years, with $68858.0 as the latest value for Q3 2020.

  • Quarterly Other Non-Current Assets changed N/A to $68858.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $68858.0 through Sep 2020, changed N/A year-over-year, with the annual reading at $122381.0 for FY2019, 86.18% up from the prior year.
  • Other Non-Current Assets hit $68858.0 in Q3 2020 for Monopar Therapeutics, down from $73050.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $800393.0 in Q4 2016 to a low of $65731.0 in Q4 2018.
  • Historically, Other Non-Current Assets has averaged $405876.3 across 5 years, with a median of $122381.0 in 2019.
  • Biggest five-year swings in Other Non-Current Assets: crashed 91.78% in 2018 and later skyrocketed 86.18% in 2019.
  • Year by year, Other Non-Current Assets stood at $800393.0 in 2016, then fell by 0.05% to $800031.0 in 2017, then plummeted by 91.78% to $65731.0 in 2018, then surged by 86.18% to $122381.0 in 2019, then tumbled by 43.73% to $68858.0 in 2020.
  • Business Quant data shows Other Non-Current Assets for MNPR at $68858.0 in Q3 2020, $73050.0 in Q2 2020, and $122381.0 in Q1 2020.